Drugs / Flubio
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02093260 | May → Jul 2014 | — | PT Bio Farma | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03695432 | Oct 2014 → Apr 2015 | influenza | Indonesia University | Completed | No outcome recorded |
Press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2019-05-31 | PT Bio Farma | Tidak Mau Pemainnya Terkena Penyakit, Pemain Persib Divaksin Flubio co.id ↗ |
| 2019-01-24 | PT Bio Farma | Bersentuhan dengan sumber penyakit, sekitar 2000 Petugas Kebersihan dan Satpol PP diimunisasi Flubio & Tetanus co.id ↗ |
| 2017-11-13 | PT Bio Farma | Jurnalis Mendapatkan Suntik Vaksin Flubio co.id ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flubio | “Flubio (Influenza HA) Vaccine” NCT02093260 ↗ |
| Modality | Vaccine | “Bio Farma Trivalent Influenza HA (Flubio®) vaccine” PMID 29551225 ↗ Mar 2018 |
| Route | Intramuscular | “The vaccine will be given intramuscularly.” NCT02093260 ↗ |